GPT and stroke disorder: As the comprehensive randomized Act- and TRACE-2 trials recently published, with non-inferior functional outcome comparing TNK with ALT (5, 30), more stroke centers worldwide are expected to switch to TNK; therefore, it is also important to further survey the safety aspects of this switch in the real-world.